Navigation Links
Affitech Announces Second Milestone in Roche Antibody Discovery Collaboration
Date:9/23/2008

OSLO, September 23 /PRNewswire/ -- Affitech AS, the Norwegian human antibody therapeutics company, today announced that it has accomplished the second milestone in its research and licensing collaboration with Roche to produce fully human recombinant antibodies against an unnamed oncology target. Affitech has successfully used its MBAS (Molecule Based Antibody Screening) system that included its proprietary antibody library and high throughput screening technology to identify several fully human lead antibody candidates. These were then subjected to further engineering in order to generate final candidates that met Roche's various predetermined success criteria. This accomplishment triggered a milestone payment of an undisclosed amount from Roche to Affitech.

"This was a particularly challenging target that Roche asked us to investigate and we are delighted to have delivered a selected group of antibodies, on schedule, that meet their exacting criteria," commented Martin Welschof, Ph.D., Chief Executive Officer of Affitech.

Affitech and Roche entered into this collaboration in 2007 for Affitech to identify and engineer fully human recombinant antibodies against one of Roche's oncology targets. Under the terms of the agreement Roche will now utilize these antibodies for further preclinical evaluation with exclusive rights to develop and commercialize resulting antibodies. Affitech would receive additional milestone payments upon successful development by Roche of these antibodies in oncology or other indications and royalties on worldwide net sales of any successfully developed product candidates.

Notes to Editors:

About Affitech

Affitech AS is a privately held human therapeutic antibody discovery and development company with headquarters and R&D facilities in Oslo, Norway and its US subsidiary in the San Francisco Bay Area. The Company's current disease focus is oncology and it utilizes two discrete but unique approaches for
'/>"/>

SOURCE Affitech AS
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Affitech Appoints Dr. Keith McCullagh as Chairman
2. Affitech and Omeros Enter Into Antibody Discovery and Development Agreement
3. BioMS Medical announces receipt of milestone payment from Eli Lilly and Company
4. Emisphere Announces Recruitment Phase III Study for Oral Osteoarthritis Treatment
5. China-Biotics, Inc. Announces Results of 2008 Annual General Meeting of Shareholders
6. BioElectronics Corp. Announces $400,000 in New Orders From the Middle East
7. The Michigan Life Sciences Pipeline Announces New Best Practices Seminars Tailored to Michigan Businesses
8. Enigma Diagnostics Announces an Award of GBP 1.8 Million From UK Government
9. Oncothyreon announces receipt of NASDAQ letter regarding compliance with NASDAQ Global Market listing standards
10. Quark Pharmaceuticals Announces Poster Presentations at RNAi Europe 2008
11. Dendreon Announces Webcast Presentation at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... (PRWEB) February 26, 2015 The ... -12, at the Ernest N. Morial Convention Center ... (count as of February 19, 2015) displaying products ... industrial, academic, and government labs. The Exposition will ... but not limited to, analytical chemistry; drug discovery; ...
(Date:2/26/2015)... MD (PRWEB) February 26, 2015 RURO, ... provider, released FreezerPro® version 6.2 – the latest update ... FreezerPro® reputation is that of a quick and easy ... work. With the latest version, RURO engineering has enhanced ... import to move large amounts of sample records. ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 Regis Technologies ... the development of oncology drug substances. , Regis Technologies ... of their new Potent Compound Suite (PCS) for 2015. ... 36,000 square foot, cGMP facility in Morton Grove, Illinois. ... manufacturing of potent compounds up to about one kilogram ...
(Date:2/26/2015)... 2015  Epic Sciences announced today that President and ... the 35th Annual Cowen and Company Health Care Conference ... Room, 3rd Floor. The conference will be held at ... Epic is developing diagnostic tests of high clinical ... changes that occur during the course of cancer treatments. ...
Breaking Biology Technology:Pittcon 2015 Announces Exposition Highlights 2RURO Releases FreezerPro® version 6.2 2Regis Extends cGMP Services to Oncology Market 2Epic Sciences to Present at 35th Annual Cowen and Company Health Care Conference 2
... Creabilis SA, a clinical stage European biotechnology company addressing ... today the expansion of its senior management team with ... Leech joins as Vice President, Head of Finance and ... Development, and Peter Spargo as Senior Vice President for ...
... MIAMI, Aug. 17, 2011 Nuovo Biologics, LLC ... a Largo, Florida veterinarian. Dr. Mandelker will supervise all ... the Company in its pursuit of FDA/CVM NADA approvals ... caused by viral infections, canine malignant melanoma, feline leukemia ...
... 2011 Planet Biopharmaceuticals, Inc. and its wholly owned ... focused on providing products for allergy and asthma sufferers, ... been named as the company,s Executive Chairman and will ... August 29, 2011. Odlaug will replace William (Bill) Goldberg, ...
Cached Biology Technology:Creabilis Expands Senior Management Team 2Creabilis Expands Senior Management Team 3Dr. Lester Mandelker to Collaborate with Nuovo Biologics, LLC 2Planet Biopharmaceuticals, Inc. Appoints Theron (Ted) Odlaug, Ph.D. as Executive Chairman 2
(Date:2/19/2015)... Feb .19, 2015 Research and Markets ... of the "Military Electro-Optical / Infrared Systems ... by Platform - Forecast to 2020" report ... electro-optical/infrared systems market is expected to reach $16.35 ... 7.71%. This report segments the military ...
(Date:2/12/2015)... OXFORD, Conn. , Feb. 12, 2015 ... ("NXT-ID" or the "Company"), a biometric authentication company focused ... it has filed provisional patent 62/113114 for ... MULTIPLE DEVICES. The patent further establishes NXT-ID,s ... to its intellectual property portfolio the ability for multiple ...
(Date:2/5/2015)... , 5. Februar 2015 Marken ... Logistikunternehmen und hat eine neue Marketingkampagne gestartet, ... (Clinical Logistics Organization – CLO) der Branche ... lautet First , mit Schwerpunkt auf ... http://photos.prnewswire.com/prnh/20150205/173753 Logo - ...
Breaking Biology News(10 mins):Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 3NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3
... The closest encounter most wildlife biologists have with wolverines in ... tracks in the snow. But wildlife biologist Keith Aubry recently ... , A member of his research team called from ... to report that a wolverine had just been captured. Aubry, ...
... protein in the brain enhances long-term storage of ... Yale School of Medicine researchers report this week ... first to demonstrate evidence of enhancements in memory ... Jane Taylor, associate professor in the Department of ...
... the odds that DNA evidence found at a crime ... person who was not there are infinitesimal, controversy continues ... says Carnegie Mellon University Statistics Professor Kathryn Roeder. Roeder ... DNA identification on Tuesday, April 25, during the Annual ...
Cached Biology News:First wolverine radio-collared in Pacific Northwest 2Activation of a protein solidifies fear memory in the brain 2DNA conclusive yet still controversial, Carnegie Mellon professor says 2
... that it uses a deep-UV deuterium bulb, which ... with a shutter (controlled via a TTL signal ... DH-2000 Deuterium Tungsten Halogen Light Source combines ... light sources in a single optical path. The ...
One controller two vessel system suitable for early stage of fermentation, and small scale, Application : cultivation of microorganisms and human or animal cells...
... save space and organize gloves, safety ... They are the perfect benchtop storage ... labs, processing and manufacturing. Clear static-dissipative ... particles they attract. Many other sizes ...
... used to reveal two distinct antigens in ... a Zymed polymer double staining detection method ... same human cell or tissue sample with ... using two different primary antibodies from mouse ...
Biology Products: